Inequality in Drug Utilization among Chronic Myeloid Leukaemia Patients in Malaysia: A Cost-Utility Analysis

BACKGROUND: The burden of chronic myeloid leukaemia (CML) is increasing due to longer patient survival, better life expectancy of the general population, and increasing drug prices. Funding is one of the main concerns in the choice of CML medication used worldwide; thus, patient assistance programme...

Descripción completa

Detalles Bibliográficos
Autores principales: Puteh, Sharifa Ezat Wan, Selamat, Ellyana Mohamad, Aizuddin, Azimatun Noor, Tumian, Nor Rafeah, Sathar, Jameela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971449/
https://www.ncbi.nlm.nih.gov/pubmed/36580008
http://dx.doi.org/10.31557/APJCP.2022.23.12.4253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971449/
https://www.ncbi.nlm.nih.gov/pubmed/36580008
http://dx.doi.org/10.31557/APJCP.2022.23.12.4253

Ejemplares similares